Abstract Submission Guidelines
Abstracts should be submitted at the latest on August 4th, 2023.
Abstracts must be written and presented in English.
Use a concise descriptive title that indicates the content of the abstract. Commercial trade names for drugs, devices, products and services may NOT be used in the title.
Names and surnames for each author must be provided. Do not include degrees or titles.
Abstracts should not exceed 250 words. Abstract that are not written in understandable English will be rejected and/or returned to the author(s) for revision. The body of the abstract text must be formatted with the following sub-headings as appropriate. Each sub-heading should begin on a new line, and followed by a colon and space (: ). The text for each sub-section should begin immediately after the colon and space.
Drugs, devices, products, and services should be identified by generic name only within the abstract.
The format of the abstract should be: Background, Objective, Methods, Results and Conclusions.
Please note that all presenters should register for the conference.
This presentation/poster shouldn't be a variation of any previous version presented at a conference
The poster should be printed by the presenter in A0 size